Successful use of recombinant factor VIIa in a haemophiliac with inhibitor undergoing cataract surgery

Blood Coagul Fibrinolysis. 2001 Apr;12(3):215-6. doi: 10.1097/00001721-200104000-00009.

Abstract

A 40-year-old patient with severe haemophilia A and an inhibitor against factor VIII underwent a cataract extraction under local anaesthesia. Recombinant activated factor VII was use to achieve haemostasis. The procedure was successful. Neither bleeding complications nor side effects occurred.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Blood Loss, Surgical / prevention & control*
  • Cataract / complications
  • Cataract Extraction*
  • Factor VIII / immunology*
  • Factor VIIa / administration & dosage
  • Factor VIIa / therapeutic use*
  • Hemophilia A / complications
  • Hemophilia A / drug therapy*
  • Hemostasis, Surgical*
  • Humans
  • Isoantibodies / immunology*
  • Male
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / therapeutic use*

Substances

  • Isoantibodies
  • Recombinant Proteins
  • Factor VIII
  • Factor VIIa